MNMD: An optimal buy Call option hereMNMD: An optimal buy Call option here
-Long ABCD pattern.
-Inversed HnS pattern forming.
-Fibo golden zone at 0.168./
-Key level support.
-Logic volume together with spread.
.
Wait n see.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.99 USD
−95.73 M USD
0.00 USD
27.25 M
About Mind Medicine (MindMed) Inc.
Sector
CEO
Robert Barrow
Headquarters
New York
Website
Founded
2010
FIGI
BBG00F13HYQ7
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
$MNMD looking for a good swing trade. On a more zoomed out NASDAQ:MNMD looks like it’s in a falling wedge. A little double bottom could be forming here as well. Will be accumulating $1500 or so in shares for a short term swing. Risk for me is $6.75 with a goal of $8.50 and leave some running.
WSL
MNMD 600% in 2025With Trump and RFK challenging the stronghold of big pharma, the suppression of psychedelic medicines may soon be over. Analysts have set a price target of $26. Market conditions and fresh speculative details render these companies highly volatile and speculative, as many are in trial phases and are
MNMD - long - multi catalyst play - risky before 03/07/2024Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances inclu
MNMD - A Good Play or a Bad Trip?First, full disclosure - I took a position in MNMD on Monday of last week after it popped over the $5.00 barrier; it was a Trade Ideas (TI) "Trade of the Week" play, and I took it after careful tech analysis and considering the successes of the TI recommendations of the past. The stock took a dump o
Mind Med - hopes for growth in Future - long term bullishPreviously dicussed on Nov 30th similarities between mj and mush stocks. Saw good price movement and a clean breakout pull back set up. So purchased at 2.99 and exited at 3.65. Subsiquently news came out which was good and New LSD testing will be good for the future of the stock. Long term play. Sti
$MNMD Volume breakout with gap fill potential payoutMNMD nice clean volume breakout with room to run in my opinion with potential big pay out on the gap fill at $5.5 zone
Good risk / reward idea , and I like the chart
MNMD6M
RSI is at a top.
MFI is at 60, not yet exhausted.
I think the RSI could hold at the top for a time on this timeframe.
1Y
RSI is at a bottom.
MFI is around 60, with a downward sloping trend.
I think we could hold a low RSI for a time on this timeframe going towards lower lows.
5Y
RSI is trending
MNMD gap fill to ~$6potential gap fill play on MNMD. would like to see some consolidation before the breakout
MNMD Long based on Fundmntls, Lvls and MetaWorldCrypto indicatorHypothesis: pharmaceutical company price depressed due to conflict between management and investor, price artificially low due to FUD.
Confluence on W1 charts:
1. Price near ATL and 2020 support levels (year of IPO), see Early 2020 Support, and 2020 Support Levels.
2. Advanced RSI in oversold ban
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MNMD is 7.32 USD — it has increased by 3.39% in the past 24 hours. Watch Mind Medicine (MindMed) Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mind Medicine (MindMed) Inc. stocks are traded under the ticker MNMD.
MNMD stock has fallen by −2.14% compared to the previous week, the month change is a 2.16% rise, over the last year Mind Medicine (MindMed) Inc. has showed a 108.55% increase.
We've gathered analysts' opinions on Mind Medicine (MindMed) Inc. future price: according to them, MNMD price has a max estimate of 55.00 USD and a min estimate of 16.00 USD. Watch MNMD chart and read a more detailed Mind Medicine (MindMed) Inc. stock forecast: see what analysts think of Mind Medicine (MindMed) Inc. and suggest that you do with its stocks.
MNMD reached its all-time high on Mar 20, 2017 with the price of 154.80 USD, and its all-time low was 0.01 USD and was reached on Dec 26, 2019. View more price dynamics on MNMD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MNMD stock is 6.68% volatile and has beta coefficient of 1.10. Track Mind Medicine (MindMed) Inc. stock price on the chart and check out the list of the most volatile stocks — is Mind Medicine (MindMed) Inc. there?
Today Mind Medicine (MindMed) Inc. has the market capitalization of 199.39 M, it has increased by 2.33% over the last week.
Yes, you can track Mind Medicine (MindMed) Inc. financials in yearly and quarterly reports right on TradingView.
Mind Medicine (MindMed) Inc. is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
MNMD earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.28 USD resulting in a 35.02% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Mind Medicine (MindMed) Inc. earnings.
Mind Medicine (MindMed) Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MNMD net income for the last quarter is −13.68 M USD, while the quarter before that showed −5.85 M USD of net income which accounts for −133.75% change. Track more Mind Medicine (MindMed) Inc. financial stats to get the full picture.
No, MNMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 57.00 employees. See our rating of the largest employees — is Mind Medicine (MindMed) Inc. on this list?
Like other stocks, MNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed) Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mind Medicine (MindMed) Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mind Medicine (MindMed) Inc. stock shows the neutral signal. See more of Mind Medicine (MindMed) Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.